ICH E14 recommends that a thorough QT/QTc (TQT) study should be performed to determine
whether intensive monitoring of QT interval in target patient populations is required during
later stages of development. The current study is designed to ascertain whether CP-690,550 is
associated with QTc prolongation.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Moxifloxacin Norgestimate, ethinyl estradiol drug combination Tofacitinib